Aktie A2QJQB VIVEVE MEDICAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Viveve Medical, Inc.

Aktien

A2QJQB

US92852W5013

VIVE

Markt geschlossen - OTC Markets
Andere Börsenplätze
 20:20:42 26.04.2024 		% 5 Tage % 1. Jan.
0,0002 USD -33,33 % Intraday Chart für Viveve Medical, Inc. -33,33 % -.--%
2023 InMode Ltd. (NasdaqGS:INMD) erwirbt geistiges Eigentum von Viveve Medical Inc. CI
2023 Sektor-Update: Aktien des Gesundheitswesens schließen in der Nähe der Tagestiefs MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows
Sector Update: Health Care Stocks Sputtering in Tuesday Trading
Top Midday Decliners
Sector Update: Health Care
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
Sector Update: Health Care
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday
Top Premarket Decliners
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
Viveve Medical to Seek Strategic Alternatives
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QJQB Aktie
  4. Nachrichten Viveve Medical, Inc.
  5. Andere Sprachen